428 research outputs found

    Analysis of dynamic characteristics of fluid force induced by labyrinth seal

    Get PDF
    Flow patterns of the labyrinth seal are experimentally investigated for making a mathematical model of labyrinth seal and to obtain the flow induced force of the seal. First, the flow patterns in the labyrinth chamber are studied on the circumferential flow using bubble and on the cross section of the seal chamber using aluminum powder as tracers. And next, the fluid force and its phase angle are obtained from the measured pressure distribution in the chamber and the fluid force coefficients are derived from the fluid force and the phase angle. Those are similar to the expression of oil film coefficients. As a result, it is found that the vortices exist in the labyrinth chambers and its center moves up and down periodically. The pressure drop is biggest in the first stage of chambers and next in the last stage of chambers

    Ku70 alleviates neurodegeneration in drosophila models of Huntington's disease

    Get PDF
    DNA damage accumulates in genome DNA during the long life of neurons, thus DNA damage repair is indispensable to keep normal functions of neurons. We previously reported that Ku70, a critical molecule for DNA double strand break (DSB) repair, is involved in the pathology of Huntington's disease (HD). Mutant huntingtin (Htt) impaired Ku70 function via direct interaction, and Ku70 supplementation recovered phenotypes of a mouse HD model. In this study, we generate multiple Drosophila HD models that express mutant huntingtin (Htt) in eye or motor neuron by different drivers and show various phenotypes. In such fly models, Ku70 co-expression recovers lifespan, locomotive activity and eye degeneration. In contrast, Ku70 reduction by heterozygous null mutation or siRNA-mediated knock down accelerates lifespan shortening and locomotion disability. These results collectively support that Ku70 is a critical mediator of the HD pathology and a candidate therapeutic target in HD

    The Amyloid-beta Pathway in Alzheimer's Disease

    Get PDF
    Breakthroughs in molecular medicine have positioned the amyloid-Ī² (AĪ²) pathway at the center of Alzheimerā€™s disease (AD) pathophysiology. While the detailed molecular mechanisms of the pathway and the spatial-temporal dynamics leading to synaptic failure, neurodegeneration, and clinical onset are still under intense investigation, the established biochemical alterations of the AĪ² cycle remain the core biological hallmark of AD and are promising targets for the development of disease-modifying therapies. Here, we systematically review and update the vast state-of-the-art literature of AĪ² science with evidence from basic research studies to human genetic and multi-modal biomarker investigations, which supports a crucial role of AĪ² pathway dyshomeostasis in AD pathophysiological dynamics. We discuss the evidence highlighting a differentiated interaction of distinct AĪ² species with other AD-related biological mechanisms, such as tau-mediated, neuroimmune and inflammatory changes, as well as a neurochemical imbalance. Through the lens of the latest development of multimodal in vivo biomarkers of AD, this cross-disciplinary review examines the compelling hypothesis- and data-driven rationale for AĪ²-targeting therapeutic strategies in development for the early treatment of AD

    Correlation effects during liquid infiltration into hydrophobic nanoporous mediums

    Full text link
    Correlation effects arising during liquid infiltration into hydrophobic porous medium are considered. On the basis of these effects a mechanism of energy absorption at filling porous medium by nonwetting liquid is suggested. In accordance with this mechanism, the absorption of mechanical energy is a result expenditure of energy for the formation of menisci in the pores on the shell of the infinite cluster and expenditure of energy for the formation of liquid-porous medium interface in the pores belonging to the infinite cluster of filled pores. It was found that in dependences on the porosity and, consequently, in dependences on the number of filled pores neighbors, the thermal effect of filling can be either positive or negative and the cycle of infiltration-defiltration can be closed with full outflow of liquid. It can occur under certain relation between percolation properties of porous medium and the energy characteristics of the liquid-porous medium interface and the liquid-gas interface. It is shown that a consecutive account of these correlation effects and percolation properties of the pores space during infiltration allow to describe all experimental data under discussion

    Occupational, domestic and environmental mesothelioma risks in the British population: a caseā€“control study

    Get PDF
    We obtained lifetime occupational and residential histories by telephone interview with 622 mesothelioma patients (512 men, 110 women) and 1420 population controls. Odds ratios (ORs) were converted to lifetime risk (LR) estimates for Britons born in the 1940s. Male ORs (95% confidence interval (CI)) relative to low-risk occupations for >10 years of exposure before the age of 30 years were 50.0 (25.8ā€“96.8) for carpenters (LR 1 in 17), 17.1 (10.3ā€“28.3) for plumbers, electricians and painters, 7.0 (3.2ā€“15.2) for other construction workers, 15.3 (9.0ā€“26.2) for other recognised high-risk occupations and 5.2 (3.1ā€“8.5) in other industries where asbestos may be encountered. The LR was similar in apparently unexposed men and women (āˆ¼1 in 1000), and this was approximately doubled in exposed workers' relatives (OR 2.0, 95% CI 1.3ā€“3.2). No other environmental hazards were identified. In all, 14% of male and 62% of female cases were not attributable to occupational or domestic asbestos exposure. Approximately half of the male cases were construction workers, and only four had worked for more than 5 years in asbestos product manufacture

    Anti-AĪ² Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease

    Get PDF
    Background:Alzheimer's disease (AD) is a neurodegenerative disorder that causes progressive memory and cognitive decline during middle to late adult life. The AD brain is characterized by deposition of amyloid Ī² peptide (AĪ²), which is produced from amyloid precursor protein by Ī²- and Ī³-secretase (presenilin complex)-mediated sequential cleavage. Induced pluripotent stem (iPS) cells potentially provide an opportunity to generate a human cell-based model of AD that would be crucial for drug discovery as well as for investigating mechanisms of the disease. Methodology/Principal Findings:We differentiated human iPS (hiPS) cells into neuronal cells expressing the forebrain marker, Foxg1, and the neocortical markers, Cux1, Satb2, Ctip2, and Tbr1. The iPS cell-derived neuronal cells also expressed amyloid precursor protein, Ī²-secretase, and Ī³-secretase components, and were capable of secreting AĪ² into the conditioned media. AĪ² production was inhibited by Ī²-secretase inhibitor, Ī³-secretase inhibitor (GSI), and an NSAID; however, there were different susceptibilities to all three drugs between early and late differentiation stages. At the early differentiation stage, GSI treatment caused a fast increase at lower dose (AĪ² surge) and drastic decline of AĪ² production. Conclusions/Significance:These results indicate that the hiPS cell-derived neuronal cells express functional Ī²- and Ī³-secretases involved in AĪ² production; however, anti-AĪ² drug screening using these hiPS cell-derived neuronal cells requires sufficient neuronal differentiation

    Pharmaceutical Metabolism in Fish: Using a 3-D Hepatic In Vitro Model to Assess Clearance

    Get PDF
    At high internal doses, pharmaceuticals have the potential for inducing biological/pharmacological effects in fish. One particular concern for the environment is their potential to bioaccumulate and reach pharmacological levels; the study of these implications for environmental risk assessment has therefore gained increasing attention. To avoid unnecessary testing on animals, in vitro methods for assessment of xenobiotic metabolism could aid in the ecotoxicological evaluation. Here we report the use of a 3-D in vitro liver organoid culture system (spheroids) derived from rainbow trout to measure the metabolism of seven pharmaceuticals using a substrate depletion assay. Of the pharmaceuticals tested, propranolol, diclofenac and phenylbutazone were metabolised by trout liver spheroids; atenolol, metoprolol, diazepam and carbamazepine were not. Substrate depletion kinetics data was used to estimate intrinsic hepatic clearance by this spheroid model, which was similar for diclofenac and approximately 5 fold higher for propranolol when compared to trout liver microsomal fraction (S9) data. These results suggest that liver spheroids could be used as a relevant and metabolically competent in vitro model with which to measure the biotransformation of pharmaceuticals in fish; and propranolol acts as a reproducible positive control

    Distinct glutaminyl cyclase expression in Edingerā€“Westphal nucleus, locus coeruleus and nucleus basalis Meynert contributes to pGlu-AĪ² pathology in Alzheimerā€™s disease

    Get PDF
    Glutaminyl cyclase (QC) was discovered recently as the enzyme catalyzing the pyroglutamate (pGlu or pE) modification of N-terminally truncated Alzheimerā€™s disease (AD) AĪ² peptides in vivo. This modification confers resistance to proteolysis, rapid aggregation and neurotoxicity and can be prevented by QC inhibitors in vitro and in vivo, as shown in transgenic animal models. However, in mouse brain QC is only expressed by a relatively low proportion of neurons in most neocortical and hippocampal subregions. Here, we demonstrate that QC is highly abundant in subcortical brain nuclei severely affected in AD. In particular, QC is expressed by virtually all urocortin-1-positive, but not by cholinergic neurons of the Edingerā€“Westphal nucleus, by noradrenergic locus coeruleus and by cholinergic nucleus basalis magnocellularis neurons in mouse brain. In human brain, QC is expressed by both, urocortin-1 and cholinergic Edingerā€“Westphal neurons and by locus coeruleus and nucleus basalis Meynert neurons. In brains from AD patients, these neuronal populations displayed intraneuronal pE-AĪ² immunoreactivity and morphological signs of degeneration as well as extracellular pE-AĪ² deposits. Adjacent AD brain structures lacking QC expression and brains from control subjects were devoid of such aggregates. This is the first demonstration of QC expression and pE-AĪ² formation in subcortical brain regions affected in AD. Our results may explain the high vulnerability of defined subcortical neuronal populations and their central target areas in AD as a consequence of QC expression and pE-AĪ² formation
    • ā€¦
    corecore